Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 648Pancreatic Neoplasms 388Carcinoma, Hepatocellular 308Stomach Neoplasms 251Rectal Neoplasms 181Colonic Neoplasms 178Esophageal Neoplasms 171Carcinoma, Non-Small-Cell Lung 170Breast Neoplasms 151Neoplasms 134Neoplasm Metastasis 131Ovarian Neoplasms 124Cholangiocarcinoma 111Lung Neoplasms 108Liver Neoplasms 107Gastrointestinal Neoplasms 101Melanoma 88Biliary Tract Neoplasms 76Prostatic Neoplasms 75Endometrial Neoplasms 73Esophageal Squamous Cell Carcinoma 68Carcinoma, Renal Cell 56Sarcoma 55Squamous Cell Carcinoma of Head and Neck 54Uterine Cervical Neoplasms 50Head and Neck Neoplasms 46Adenocarcinoma Of Esophagus 46Urinary Bladder Neoplasms 40Triple Negative Breast Neoplasms 40Anus Neoplasms 36

Interventions

Sodium Chloride 1Amiodarone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atrial Fibrillation × Gastrointestinal × 90 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡